Matinas BioPharma Holdings, Inc. (MTNB) News
Track canonical SquawkNews coverage tagged to MTNB, Matinas BioPharma Holdings, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Top Small Cap Positive News Movers Premarket: LGHL: +120% Momentum Mover MTNB: +62% Sales Agreement Terminated DFNS: +59% SC 13D Filed BIYA
Top Small Cap Positive News Movers Premarket: LGHL: +120% Momentum Mover MTNB: +62% Sales Agreement Terminated DFNS: +59% SC 13D Filed BIYA: +44% Momentum Mover VTAK: +29% Partners with 319 Golf Society and Named Exclusi
EQUITY | Jul 27, 2026, 12:16 PM UTC
L
MTNB Gh power- Gh power equityholders to own 91% and matinas equityholders 9% of ghp international after closing Gh power - each matinas sha
MTNB Gh power- Gh power equityholders to own 91% and matinas equityholders 9% of ghp international after closing Gh power - each matinas share to be converted into 0.1 ghp international share at closing - Gh power pursui
EQUITY | Jul 13, 2026, 07:48 PM UTC
L
MTNB Gh power, the pioneering clean energy and critical Materials company, to go public through business combination with matinas Biopharma
MTNB Gh power, the pioneering clean energy and critical Materials company, to go public through business combination with matinas Biopharma Gh power - Gh power international to become public Parent company of Gh power an
EQUITY | Jul 13, 2026, 07:46 PM UTC
H
Matinas BioPharma to Merge With GH Power; Signs Deal to Sell Subsidiary, Lead Product Candidate
() -- Matinas BioPharma (MTNB) said Monday it has agreed to a definitive business combination with GH Power, a developer of proprietary modular reactor systems. Under the terms, GH Power and Matinas will become subsidiar
MNA | Jul 13, 2026, 01:03 PM UTC
L
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX: CANF ) stock moved upwards by 52.0% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $6.3 million. Atlantic International (NASDAQ: ATLN ) shares rose 17
EQUITY | Jul 01, 2026, 12:05 PM UTC
M
MTNB: Noncompliance Letter
Matinas BioPharma obtains NYSE noncompliance letter
REGULATION | Jun 26, 2026, 11:20 PM UTC